Top Story

SCALE trials: Saxenda promotes weight loss, improves health-related quality of life

May 22, 2015

NASHVILLE, Tenn. - The weight-loss drug Saxenda offers similar benefits across races and was shown to improve health-related quality of life, including physical function and mental health, according to study findings presented here.

In a series of studies analyzing data from the Satiety and Clinical Adiposity - Liraglutide Evidence (SCALE) trials, researchers also demonstrated that adverse gastrointestinal events from Saxenda (liraglutide, Novo Nordisk), including nausea and vomiting, did not affect weight loss.

Meeting News Coverage

Analysis: Most patients prescribed Qsymia as intended

May 22, 2015
NASHVILLE, Tenn. - Adults assigned the weight-loss drug Qsymia are mostly women and white, with a large percentage also taking medications for diabetes and hypertension…
Meeting News CoveragePerspective

Metformin plays role in reducing MI, heart failure risk

May 21, 2015
NASHVILLE, Tenn. — Even slight weight effects associated with metformin use may reduce risk for myocardial infarction and heart failure, according to a presenter…
In the Journals

Prevalence of metabolic syndrome high in US adults

May 20, 2015
More than one-third of U.S. adults and half of those aged 60 years or older were estimated to have metabolic syndrome in 2011-2012, according to findings in a new…
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
thumbnail for video 3857694319001

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he…
More »
Meeting News Coverage

SCALE trials: Saxenda promotes weight loss, improves health-related quality of life

May 22, 2015
NASHVILLE, Tenn. - The weight-loss drug Saxenda offers similar benefits across races and was shown to improve health-related quality of life…
Meeting News Coverage

Analysis: Most patients prescribed Qsymia as intended

May 22, 2015
NASHVILLE, Tenn. - Adults assigned the weight-loss drug Qsymia are mostly women and white, with a large percentage also taking medications for…
Meeting News CoveragePerspective

Metformin plays role in reducing MI, heart failure risk

May 21, 2015
NASHVILLE, Tenn. — Even slight weight effects associated with metformin use may reduce risk for myocardial infarction and heart failure…
In the Journals

Prevalence of metabolic syndrome high in US adults

May 20, 2015
More than one-third of U.S. adults and half of those aged 60 years or older were estimated to have metabolic syndrome in 2011-2012, according to…
Roland Schmieder In the Journals

Treatment targets differ for patients with type 2 diabetes, hypertension

May 20, 2015
Patient characteristics and overall comorbidity are used by treating physicians when deciding on individualized glucose and blood pressure targets…
Meeting News CoveragePerspective

Cardiac, sudomotor autonomic dysfunction in diabetes improve after bariatric surgery

May 19, 2015
NASHVILLE, Tenn. — Bariatric surgery restored some cardiac autonomic and sudomotor peripheral C-fiber function in patients with obesity and…
Caldwell Esselstyn Meeting News Coverage

Whole-food, plant-based diet key to reversing CVD

May 18, 2015
NASHVILLE, Tenn. — Coronary heart disease is a “benign, foodborne illness” that can be stopped or even reversed by avoiding a…
Zdravko Kamenov Meeting News Coverage

Neck circumference surpasses waist measurement as predictor of metabolic risk

May 16, 2015
NASHVILLE, Tenn. — A patient’s neck circumference may be a better indicator of fat mass and thus more predictive of metabolic risk than…
Merril Mageli Meeting News Coverage

CV biomarkers unchanged following oral testosterone therapy

May 15, 2015
NASHVILLE, Tenn. — Daily oral testosterone did not significantly increase biomarkers of cardiovascular risk in hypogonadal men, compared with…
Meeting News Coverage

High-protein diet may lead to weight gain, mortality in high-risk CVD adults

May 8, 2015
Adults at high risk for cardiovascular disease should avoid a high-protein diet, which can put them at greater risk for weight gain and death…
More Headlines »